Ubrelvy and Gastrointestinal disorder - a phase IV clinical study of FDA data

Summary:

Gastrointestinal disorder is reported as a side effect among people who take Ubrelvy (ubrogepant), especially for people who are female, 50-59 old, also take Proair Hfa, and have Migraine.

The phase IV clinical study analyzes which people have Gastrointestinal disorder when taking Ubrelvy. It is created by eHealthMe based on reports of 3,537 people who have side effects when taking Ubrelvy from the FDA, and is updated regularly.

What is Ubrelvy?

Ubrelvy has active ingredients of ubrogepant. eHealthMe is studying from 3,585 Ubrelvy users. Check the latest studies of Ubrelvy.

What is Gastrointestinal disorder?

Gastrointestinal disorder (functional problems of gastrointestinal tract) is found to be associated with 2,095 drugs and 1,909 conditions by eHealthMe. Check the latest studies of Gastrointestinal disorder.

On Jul, 19, 2026

3,537 people reported to have side effects when taking Ubrelvy.
Among them, 14 people (0.4%) have Gastrointestinal disorder.

Could Ubrelvy cause Gastrointestinal disorder?

Among these 14 people:

What is the gender of people who have Gastrointestinal disorder when taking Ubrelvy? *

female: 84.62 %
male: 15.38 %

What is the age of people who have Gastrointestinal disorder when taking Ubrelvy? *

What are other drugs people take besides Ubrelvy? *

Ibuprofen: 4 people, 28.57%
Alprazolam: 4 people, 28.57%
Proair Hfa: 4 people, 28.57%
Juxtapid: 3 people, 21.43%
Prednisone: 3 people, 21.43%
Cyclobenzaprine Hydrochloride: 2 people, 14.29%
Imitrex: 2 people, 14.29%
Ondansetron: 2 people, 14.29%
Orencia: 2 people, 14.29%
Otezla: 2 people, 14.29%

What are other side effects people have besides Gastrointestinal disorder? *

Nausea And Vomiting: 3 people, 21.43%
Alcoholism (problems with alcohol): 2 people, 14.29%
Hepatic Enzyme Increased: 2 people, 14.29%
Hepatic Enzyme Abnormal: 2 people, 14.29%
Nausea (feeling of having an urge to vomit): 2 people, 14.29%
Pain: 2 people, 14.29%
Weight Decreased: 1 person, 7.14%
Fatigue (feeling of tiredness): 1 person, 7.14%
Hoarseness Or Changing Voice: 1 person, 7.14%
Haemorrhoids (a swollen vein or group of veins in the region of the anus): 1 person, 7.14%

What are the existing conditions these people have? *

Migraine (headache): 4 people, 28.57%
Acromegaly (body produces too much growth hormone, leading to excess growth of body tissues): 2 people, 14.29%
Short-Bowel Syndrome (a condition in which the body cannot absorb enough fluids and nutrients because part of the small intestine is missing): 1 person, 7.14%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 1 person, 7.14%
Nausea And Vomiting: 1 person, 7.14%
Nausea (feeling of having an urge to vomit): 1 person, 7.14%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 1 person, 7.14%
Malnutrition (a condition that results from eating a diet in which certain nutrients are lacking): 1 person, 7.14%
Irritable Bowel Syndrome: 1 person, 7.14%
Hypothalamo-Pituitary Disorder (loss of function in an endocrine gland due to failure of the pituitary gland to secrete hormones which stimulate that gland's function): 1 person, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Ubrelvy and have Gastrointestinal disorder?

- Check whether Gastrointestinal disorder is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Ubrelvy:

Ubrelvy (3,585 reports)

Browse all side effects of Ubrelvy:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Gastrointestinal disorder:

Gastrointestinal disorder (2,095 drugs)

Browse all the conditions that are associated with Gastrointestinal disorder:

Gastrointestinal disorder (1,909 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on ubrogepant (the active ingredients of Ubrelvy) and Ubrelvy (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.